Should Celiac Disease Be Evaluated with Serologic Testing?
Yes, celiac disease should absolutely be evaluated with serologic testing in this patient with persistent bloating and gas, as these are common presentations of celiac disease and serologic testing is highly accurate, non-invasive, and essential before any dietary modifications are made.
Rationale for Testing
Celiac disease affects approximately 1% of the population, yet only 24% of those with the disease are diagnosed 1. Bloating and gastrointestinal symptoms are present in 43-85% of newly diagnosed celiac disease patients 2, making this presentation entirely consistent with undiagnosed celiac disease. The prevalence of celiac disease in patients with chronic gastrointestinal symptoms referred to secondary care ranges from 3-10% 2, which is substantially higher than the general population.
Critical Timing Consideration
It is imperative that serologic testing be performed BEFORE any gluten-free diet is initiated 3, 4. The patient must be consuming a gluten-containing diet (at least 1-3 slices of wheat bread daily for 1-3 months) at the time of testing to ensure accuracy 3, 4. Reducing or avoiding gluten prior to testing significantly reduces the sensitivity of both serology and biopsy 4.
Recommended Testing Algorithm
The appropriate serologic workup includes 1, 3:
- IgA anti-tissue transglutaminase (tTG-IgA) - the preferred initial test
- Total IgA level - essential to identify IgA deficiency (present in ~2-3% of celiac patients)
- IgA endomysial antibodies (EMA) - if tTG-IgA is weakly positive in adults
- IgA deamidated gliadin peptide (DGP) - for additional sensitivity
If IgA deficiency is detected, use IgG-based testing: IgG tTG, IgG DGP, or IgG EMA 1, 3.
Interpretation and Next Steps
- Strongly positive tTG-IgA (>10x upper limit of normal) combined with positive EMA has virtually 100% positive predictive value for celiac disease 4
- Seropositive adults should be referred for upper endoscopy with duodenal biopsies (at least 4-6 biopsies: 1-2 from bulb, 4+ from distal duodenum) to confirm diagnosis 1, 5
- Negative serology does not completely exclude celiac disease - seronegative celiac disease accounts for 6.4-7% of cases 2. If clinical suspicion remains high despite negative serology, duodenal biopsy should still be pursued
Important Clinical Pitfalls
Do not confuse symptom improvement on a low-FODMAP diet with exclusion of celiac disease. Wheat contains fructans (a FODMAP), so a low-FODMAP diet inadvertently reduces gluten exposure, potentially masking celiac disease 6. The patient's symptom persistence after the low-FODMAP trial actually increases the pre-test probability that another diagnosis like celiac disease is present.
Left undiagnosed, celiac disease leads to significant morbidity including osteoporosis, infertility, small bowel cancer, and substantially impaired quality of life 1. The only effective treatment is lifelong adherence to a strict gluten-free diet, which requires confirmed diagnosis before implementation.
Why This Takes Priority
Unlike functional disorders or FODMAP sensitivity, celiac disease is an autoimmune condition with serious long-term complications if untreated. The testing is straightforward, highly accurate (sensitivity 88-97.7%, specificity 87.4-99.6% depending on age and antibody type 1), and must be done while the patient is consuming gluten. Delaying this evaluation risks either missing a treatable autoimmune disease or forcing the patient to undergo a prolonged gluten challenge later if they empirically start a gluten-free diet 7.